Takeda Pharmaceutical (TYO:4502) has an average rating of overweight and mean price target of 6,264.50 yen, according to analysts polled by FactSet.
What else is happening in Research?
Research
UBS Upgrades Cameco to Buy From Neutral, CA$166 Price Target
UBS Upgrades Cameco to Buy From Neutral, CA$166 Price Target
$CCJ
Research
BofA Securities Initiates Coverage on Clean Harbors With Buy Rating, $360 Price Target
Clean Harbors (CLH) has an average rating of overweight and mean price target of $332.07, according to analysts polled by FactSet.Price: $302.77, Change: $-0.98, Percent Change: -0.32%
$CLH
Research
RBC Raises Price Target on Tenet Healthcare to $283 From $236, Keeps Outperform Rating
Tenet Healthcare (THC) has an average rating of buy and mean price target of $255, according to analysts polled by FactSet.
$THC